<VariationArchive VariationID="1071602" VariationName="NM_001040716.2(PC):c.3102dup (p.Thr1035fs)" VariationType="Duplication" Accession="VCV001071602" Version="5" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2021-05-10" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1062459" VariationID="1071602">
      <GeneList>
        <Gene Symbol="PC" FullName="pyruvate carboxylase" GeneID="5091" HGNC_ID="HGNC:8636" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="66848420" stop="66958383" display_start="66848420" display_stop="66958383" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="66615996" stop="66725846" display_start="66615996" display_stop="66725846" Strand="-" />
          </Location>
          <OMIM>608786</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001040716.2(PC):c.3102dup (p.Thr1035fs)</Name>
      <CanonicalSPDI>NC_000011.10:66849655:A:AA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>11q13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="66849655" stop="66849656" display_start="66849655" display_stop="66849656" variantLength="1" positionVCF="66849655" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="66617126" stop="66617127" display_start="66617126" display_stop="66617127" variantLength="1" positionVCF="66617126" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
      </Location>
      <ProteinChange>T1035fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.66849656dup" Assembly="GRCh38">
            <Expression>NC_000011.10:g.66849656dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.66617127dup" Assembly="GRCh37">
            <Expression>NC_000011.9:g.66617127dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008319.1" sequenceAccession="NG_008319" sequenceVersion="1" change="g.113721dup">
            <Expression>NG_008319.1:g.113721dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000920.4" sequenceAccession="NM_000920" sequenceVersion="4" change="c.3102dup">
            <Expression>NM_000920.4:c.3102dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000911.2" sequenceAccession="NP_000911" sequenceVersion="2" change="p.Thr1035fs">
            <Expression>NP_000911.2:p.Thr1035fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001040716.2" sequenceAccession="NM_001040716" sequenceVersion="2" change="c.3102dup" MANESelect="true">
            <Expression>NM_001040716.2:c.3102dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001035806.1" sequenceAccession="NP_001035806" sequenceVersion="1" change="p.Thr1035fs">
            <Expression>NP_001035806.1:p.Thr1035fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_022172.3" sequenceAccession="NM_022172" sequenceVersion="3" change="c.3102dup">
            <Expression>NM_022172.3:c.3102dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_071504.2" sequenceAccession="NP_071504" sequenceVersion="2" change="p.Thr1035fs">
            <Expression>NP_071504.2:p.Thr1035fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="rs" ID="2135789146" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001040716.2(PC):c.3102dup (p.Thr1035fs) AND Pyruvate carboxylase deficiency" Accession="RCV001384114" Version="5">
        <ClassifiedConditionList TraitSetID="532">
          <ClassifiedCondition DB="MedGen" ID="C0034341">Pyruvate carboxylase deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-01-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2020-01-14" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-05-10" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12112657</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19306334</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="532" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5842" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Pyruvate Carboxylase Deficiency Disease</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">ATAXIA WITH LACTIC ACIDOSIS II</ElementValue>
                <XRef Type="MIM" ID="266150" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Pyruvate carboxylase deficiency</ElementValue>
                <XRef ID="Pyruvate+carboxylase+deficiency/6120" DB="Genetic Alliance" />
                <XRef ID="87694001" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">PC deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Ataxia with lactic acidosis 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leigh necrotizing encephalopathy due to pyruvate carboxylase deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Leigh syndrome due to pyruvate carboxylase deficiency</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7512" />
                <XRef ID="7512" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Pyruvate carboxylase (PC) deficiency is characterized in most affected individuals by failure to thrive, developmental delay, recurrent seizures, and metabolic acidosis. Three clinical types are recognized: Type A (infantile form), in which most affected children die in infancy or early childhood. Type B (severe neonatal form), in which affected infants have hepatomegaly, pyramidal tract signs, and abnormal movement and die within the first three months of life. Type C (intermittent/benign form), in which affected individuals have normal or mildly delayed neurologic development and episodic metabolic acidosis.</Attribute>
                <XRef ID="NBK6852" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301764</ID>
                <ID Source="BookShelf">NBK6852</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG, ACT Sheet, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Citrullinemia.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Newborn Screening ACT Sheet, [Elevated Citrulline], Amino Acidemia/Urea Cycle Disorder, 2022</CitationText>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG Algorithm, 2022">
                <URL>https://www.acmg.net/PDFLibrary/Citrulline-Algorithm.pdf</URL>
                <CitationText>American College of Medical Genetics and Genomics, Elevated Citrulline: Amino Acidemia Algorithm, 2022</CitationText>
              </Citation>
              <XRef ID="3008" DB="Orphanet" />
              <XRef ID="C0034341" DB="MedGen" />
              <XRef ID="MONDO:0009949" DB="MONDO" />
              <XRef Type="MIM" ID="266150" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3109139" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="9367389|MedGen:C0034341" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001583499" DateUpdated="2024-02-20" DateCreated="2021-05-10" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-01-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12112657</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19306334</ID>
          </Citation>
          <Comment>This variant has not been reported in the literature in individuals with PC-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change creates a premature translational stop signal (p.Thr1035Tyrfs*15) in the PC gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PC are known to be pathogenic (PMID: 12112657, 19306334). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PC" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.66617126_66617127insA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0034341" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12699154</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3109139" TraitType="Disease" MappingType="XRef" MappingValue="C0034341" MappingRef="MedGen">
        <MedGen CUI="C0034341" Name="Pyruvate carboxylase deficiency" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

